FDA Advisory Panel Votes To Support Pfizer’s Covid-19 Vaccine For Children Ages 5-11

Pfizer's request to roll out COVID-19 vaccines for Americans as young as 5 years old cleared a key regulatory hurdle Tuesday, after a panel of the Food and Drug Administration's outside vaccine advisers voted by a majority to back Pfizer's request.